15-Hydroxyeicosatetraenoic acid: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:15-Hydroxyeicosatetraenoic acid}} | {{DISPLAYTITLE:15-Hydroxyeicosatetraenoic acid}} | ||
== 15-Hydroxyeicosatetraenoic acid == | |||
[[File:15(S)-HETE.svg|thumb|right|Chemical structure of 15(S)-HETE]] | |||
'''15-Hydroxyeicosatetraenoic acid''' (15-HETE) is a [[hydroxyeicosatetraenoic acid]] derived from the [[arachidonic acid]] metabolic pathway. It is a biologically active lipid mediator involved in various physiological and pathological processes. | |||
15-HETE | |||
=== | == Biosynthesis == | ||
15-HETE is primarily synthesized through the action of the enzyme [[15-lipoxygenase]] (15-LOX) on arachidonic acid. This enzyme catalyzes the oxygenation of arachidonic acid to produce 15(S)-hydroperoxyeicosatetraenoic acid (15(S)-HPETE), which is subsequently reduced to 15(S)-HETE. | |||
15-HETE is | |||
== | == Biological Functions == | ||
== | 15-HETE plays a role in the regulation of [[inflammation]], [[immune response]], and [[vascular homeostasis]]. It acts as a signaling molecule influencing the behavior of various cell types, including [[endothelial cells]], [[smooth muscle cells]], and [[leukocytes]]. | ||
15-HETE can | |||
=== Inflammation === | |||
In the context of inflammation, 15-HETE can have both pro-inflammatory and anti-inflammatory effects, depending on the cellular context and the presence of other mediators. It is involved in the resolution phase of inflammation by promoting the clearance of inflammatory cells and the restoration of tissue homeostasis. | |||
=== Vascular System === | |||
In the vascular system, 15-HETE modulates [[vasodilation]] and [[vasoconstriction]], influencing blood flow and [[blood pressure]]. It can affect the function of [[endothelial cells]] and [[smooth muscle cells]], contributing to the regulation of vascular tone. | |||
== Clinical Significance == | |||
15-HETE has been implicated in various diseases, including [[asthma]], [[atherosclerosis]], and certain types of [[cancer]]. Its levels are often altered in pathological conditions, making it a potential biomarker for disease diagnosis and progression. | |||
=== Asthma === | |||
In [[asthma]], 15-HETE is involved in the inflammatory response and airway remodeling. It can influence the contraction of airway smooth muscle and the production of mucus, contributing to the symptoms of asthma. | |||
=== Atherosclerosis === | |||
In [[atherosclerosis]], 15-HETE is involved in the formation of [[atherosclerotic plaques]] and the regulation of [[lipid metabolism]]. It can affect the behavior of [[macrophages]] and [[foam cells]], playing a role in plaque stability and progression. | |||
== Related Pages == | |||
* [[Arachidonic acid]] | * [[Arachidonic acid]] | ||
* [[ | * [[Eicosanoids]] | ||
* [[Lipoxygenase]] | * [[Lipoxygenase]] | ||
* [[Inflammation]] | * [[Inflammation]] | ||
[[Category:Eicosanoids]] | [[Category:Eicosanoids]] | ||
[[Category: | [[Category:Biochemistry]] | ||
Latest revision as of 06:12, 16 February 2025
15-Hydroxyeicosatetraenoic acid[edit]
-HETE.svg)
15-Hydroxyeicosatetraenoic acid (15-HETE) is a hydroxyeicosatetraenoic acid derived from the arachidonic acid metabolic pathway. It is a biologically active lipid mediator involved in various physiological and pathological processes.
Biosynthesis[edit]
15-HETE is primarily synthesized through the action of the enzyme 15-lipoxygenase (15-LOX) on arachidonic acid. This enzyme catalyzes the oxygenation of arachidonic acid to produce 15(S)-hydroperoxyeicosatetraenoic acid (15(S)-HPETE), which is subsequently reduced to 15(S)-HETE.
Biological Functions[edit]
15-HETE plays a role in the regulation of inflammation, immune response, and vascular homeostasis. It acts as a signaling molecule influencing the behavior of various cell types, including endothelial cells, smooth muscle cells, and leukocytes.
Inflammation[edit]
In the context of inflammation, 15-HETE can have both pro-inflammatory and anti-inflammatory effects, depending on the cellular context and the presence of other mediators. It is involved in the resolution phase of inflammation by promoting the clearance of inflammatory cells and the restoration of tissue homeostasis.
Vascular System[edit]
In the vascular system, 15-HETE modulates vasodilation and vasoconstriction, influencing blood flow and blood pressure. It can affect the function of endothelial cells and smooth muscle cells, contributing to the regulation of vascular tone.
Clinical Significance[edit]
15-HETE has been implicated in various diseases, including asthma, atherosclerosis, and certain types of cancer. Its levels are often altered in pathological conditions, making it a potential biomarker for disease diagnosis and progression.
Asthma[edit]
In asthma, 15-HETE is involved in the inflammatory response and airway remodeling. It can influence the contraction of airway smooth muscle and the production of mucus, contributing to the symptoms of asthma.
Atherosclerosis[edit]
In atherosclerosis, 15-HETE is involved in the formation of atherosclerotic plaques and the regulation of lipid metabolism. It can affect the behavior of macrophages and foam cells, playing a role in plaque stability and progression.
